WebJun 21, 2024 · Spirea will use its revolutionary technology to build a pipeline of proprietary and partnered ADC therapeutics. As well as developing its own drugs, the company plans to collaborate with partners on new programmes and to revive pre-existing preclinical and clinical-stage assets that have failed because of narrow therapeutic index. WebDec 7, 2024 · Spirea Limited, a spin-out from the University of Cambridge, which was founded to deliver the next generation of antibody drug conjugate (ADC) cancer therapeutics, has today announced that it has secured financing from lead o2h Ventures and Syndicate Room.

Our Company - Aprea

WebI am Myriam Ouberai, CEO and Founder of Spirea. Our venture has developed an exciting and flexible new approach to building antibody drug conjugate (ADC) cancer therapeutics that … WebApr 25, 2024 · Firelight. Glow Girl. Japanese White. Snowmound. Vanhouttei. 1. Anthony Waterer. S. x bumalda ‘Anthony Waterer’ is a garden classic with a compact, mounded form, colorful foliage, and multiple flat-topped umbels of … movie theaters crystal city va

Spirea raises £2.4M to develop antibody drug conjugates in cancer

WebJun 16, 2024 · Photo/Shutterstock. Funding of £2.4 million ($2.9 million) has been secured by UK-based company, Spirea Limited, to advance a new generation of antibody drug conjugate (ADC) therapeutics. The company will use the funds to initiate its pipeline of ADCs in the treatment of solid tumors where they say there is a high unmet need. WebDec 7, 2024 · Spirea, a biotech company spun out from the University of Cambridge, is committed to delivering the next generation of antibody drug conjugate (ADC) therapeutics to revolutionise cancer treatment and improve the lives of patients. WebSpirea Limited is a Cambridge-based company created to advance a new generation of antibody-targeted cancer treatments with significantly better efficacy and safety profiles. … movie theater screen size ratio